Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN118440041B details a novel seven-step synthesis for high purity chiral intermediates. This method ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Advanced Pt/Bi catalytic hydrogenation technology for m-aminoacetophenone. Delivers superior selectivity, green processing, and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN102234240B details a high-yield L-BMAA synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable supply solutions.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1213998C details a novel route for antifolate intermediates using stable sulfonic acid salts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Advanced synthesis of Nifuratel avoiding hazardous reagents. Cost-effective pharmaceutical intermediates manufacturing with improved safety and scalability.
Patent CN114773316A details a scalable Grignard-based route for 2-(2,6-dioxo-piperidin-3-yl)-5-fluoro-isoindole-1,3-dione, offering high purity and cost-effective manufacturing for PROTAC intermediates.
Patent CN113683566A details a novel solvent-free synthesis of Edaravone achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN1098272C reveals a novel ether-silyl protection strategy for clarithromycin, offering high selectivity and cost reduction in antibiotic manufacturing for global supply chains.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.
Patent CN116903499B reveals a novel anhydrous copper salt synthesis enabling cost reduction in pharmaceutical intermediate manufacturing and high-purity trifluoromethylation.
Advanced patent CN106045970A details high-yield Efinaconazole intermediate production with reduced impurities and scalable mild conditions for supply chain stability.
Novel two-step route offers high purity pharmaceutical intermediates with reduced costs and scalable production capabilities for global supply chains ensuring reliability.
Patent CN101701243B details a high-efficiency biocatalytic route for R-mandelic acid using Alcaligenes faecalis, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116023401B reveals mild photoredox synthesis for chiral borates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced Wittig reaction protocol for high-purity cephalosporin intermediates. Optimized Z-isomer selectivity and scalable manufacturing for oral antibiotics.
Patent CN116023401B reveals mild photoredox nickel catalysis for chiral borates. Enables high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Advanced solvent exchange crystallization for Ezetimibe intermediates ensuring over 99 percent purity and ee value for global pharmaceutical supply chains.
Patent CN102964337A details a novel alkaline oxidation route for Esomeprazole, offering superior optical purity and cost-effective manufacturing for global pharmaceutical supply chains.